Literature DB >> 9924590

Transcutaneous measurement of hyperbilirubinaemia: comparison of the Minolta jaundice meter and the Ingram icterometer.

H Bilgen1, Z Ince, E Ozek, N Bekiroglu, R Ors.   

Abstract

The effectiveness of two different non-invasive transcutaneous bilirubin measurement devices was compared with serum bilirubin levels in 96 healthy newborns. Transcutaneous measurements were obtained with the Minolta Air Shields jaundice meter and the Ingram icterometer and serum bilirubin levels were determined by a direct spectrophotometric method (Bilitron 444). A linear correlation existed between serum bilirubin values and the readings on both the Minolta jaundice meter (r = 0.83) and the Ingram icterometer (r = 0.78). The Kappa coefficient was 0.66. the sensitivity, specificity and positive and negative predictive values were 100%, 56%, 33% and 100% for the Minolta jaundice meter and 100%, 48%, 29% and 100% for the Ingram icterometer, respectively. The high sensitivity and negative predictive value of both devices render them suitable for screening neonatal hyperbilirubinaemia. However, because of its low cost, the Ingram icterometer is preferable to the more complex and expensive Minolta jaundice meter, especially in countries with a high birth rate, such as Turkey.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924590     DOI: 10.1080/02724936.1998.11747968

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  3 in total

1.  Estimation of bilirubin using BiliChektrade mark, a transcutaneous bilirubin measurement device: Effects of gestational age and use of phototherapy.

Authors:  Ka Jangaard; H Curtis; Rb Goldbloom
Journal:  Paediatr Child Health       Date:  2006-02       Impact factor: 2.253

2.  Detection of hyperbilirubinaemia in jaundiced full-term neonates by eye or by bilirubinometer?

Authors:  Peter Szabo; Martin Wolf; Hans Ulrich Bucher; Jean-Claude Fauchère; Daniel Haensse; Romaine Arlettaz
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

Review 3.  Screening methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments.

Authors:  Christian V Hulzebos; Libor Vitek; Carlos D Coda Zabetta; Aleš Dvořák; Paul Schenk; Eline A E van der Hagen; Christa Cobbaert; Claudio Tiribelli
Journal:  Pediatr Res       Date:  2021-05-03       Impact factor: 3.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.